Welcome to the Kids' Library!

Acceptable risks politics, policy, and risky technologies

Heimann, C. F. Larry (Clarence Fredrick)
Ann Arbor : University of Michigan Press, c1997. 1997

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

The adequacy of FDA to assure the safety of the nation's drug supply hearing before the Subcommittee

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

Advancing the discipline of regulatory science for medical product development : an update on progre

Washington, District of Columbia : The National Academies Press, 2016. 2016

Antibiotic use in food animals : FDA's current activities

Greene, Joel L., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Assuring data quality and validity in clinical trials for regulatory decision making workshop report

Washington, DC : National Academy Press, c1999. 1999

Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the C

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

The challenge to improve patient safety FDA logs over 350,000 reports of adverse events annually.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2002] 2002

Chemical risk assessment : selected federal agencies' procedures, assumptions, and policies : report

United States. General Accounting Office.
[Washington, D.C.] : The Office, [2001] 2001

Confronting cancer FDA's long fight against America's bane.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2002] 2002

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2001. 2001

Cost-contained regulatory compliance for the pharmaceutical, biologics, and medical device industrie

Weinberg, Sandy, 1950-
Hoboken, N.J. : John Wiley & Sons, c2011. 2011

Date labels on packaged foods : USDA and FDA could take additional steps to reduce consumer confusio

United States. Government Accountability Office, author.
Washington, DC : United States Government Accountability Office, 2019. 2019

Development and approval of combination products a regulatory perspective

Hoboken, N.J. : Wiley, c2008. 2008

Development of FDA-regulated medical products : a translational approach

Whitmore, Elaine, author.
Milwaukee, Wisconsin : ASQ Quality Press, 2012. 2012

Development of FDA-regulated medical products : a translational approach

Whitmore, Elaine, author.
Milwaukee, Wisconsin : ASQ Quality Press, 2012. 2012

Dietary supplements uncertainties in analyses underlying FDA's proposed rule on ephedrine alkaloids

United States. General Accounting Office.
Washington, D.C. : (441 G St., NW, Rm. LM, Washington, 20548) : U.S. General Accounting Office, [1999] 1999

Diminished capacity can the FDA assure the safety and security of the nation's food supply? : Hearin

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Discussion draft of the Food and Drug Administration Globalization Act legislation device and cosmet

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Dr. Watt's trial.

Wichita, Kan. : Defender Publishers, [1956?]. 1956

Drug compounding clear authority and more reliable data needed to strengthen FDA oversight : report

United States. Government Accountability Office, issuing body.
[Washington, D.C.] : United States Government Accountability Office, 2013. 2013

Drug safety an update from the Food and Drug Administration : hearing before the Subcommittee on Hea

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2012. 2012

Drug safety most drugs withdrawn in recent years had greater health risks for women

United States. General Accounting Office.
Washington, D.C. : The Office, [2001] 2001

Drug safety: FDA should take additional steps to improve its Foreign Inspection Program : report to

United States. Government Accountability Office, author.
Washington, DC : U.S. Government Accountability Office, 2022. 2022

Drug shortages FDA's ability to respond should be strengthened : report to congressional requesters.

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011] 2011

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Educ

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

An effective defense against breast cancer FDA's mammography quality standards program.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2003] 2003

Efforts to address the safety of FDA-regulated food imports

Johnson, Renée (Specialist in agricultural policy), author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Enhancing food safety the role of the Food and Drug Administration

Institute of Medicine (U.S.). Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food.
Washington, D.C. : National Academies Press, c2010. 2010

Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005. 2005

Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020] 2020

FDA Amendments Act of 2007 (P.L. 110-85)

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA and the drug development process how the agency ensures that drugs are safe and effective.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2002] 2002

FDA-approved bargain drugs generic products must meet high standards.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2003] 2003

The FDA Commission : the delegation of authority to state and local authorities.

Rockville, Md : U.S. Dept. of Human Services, Public Health Service, Food and Drug Administration, [1986?] 1986

FDA drug approval review time has decreased in recent years : report to congressional requesters.

United States. General Accounting Office.
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1995] 1995

FDA fights rare diseases new help for patients without treatments.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2002] 2002

FDA foreign drug inspection program a system at risk : hearing before the Subcommittee on Oversight

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

The FDA medical device user fee program

Johnson, Judith A. (Judith Ann), 1957- author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

FDA protetects the public health ranks high in public trust.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2002] 2002

FDA regulation of laboratory-developed tests (LDTs)

Sarata, Amanda K., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

FDA regulation of tobacco products

Green, Victoria R., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA regulation of tobacco products

New York : Nova Science, c2009. 2009

FDA tobacco regulation : the Family Smoking Prevention and Tobacco Control Act of 2009

Redhead, C. Stephen, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA a history

[Los Angeles] : Choices, [2010] 2010

FDA workforce: agency-wide workforce planning needed to ensure medical product staff meet current an

United States. Government Accountability Office, author.
Washington, DC : United States Government Accountability Office, 2022. 2022

FDA's authority to ensure that drugs prescribed to children are safe and effective

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education,

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005. 2005

FDA's foreign drug inspection program weaknesses place Americans at risk : hearing before the Subcom

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

FDA's global shield for American consumers the agency acts worldwide to ensure high quality imports.

Rockville, MD : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, [2003] 2003